I am living with a pain in the rear. Casey Abrams, a musician and American Idol alumnus, would say I am living with a “chip on my shoulder,” but I prefer to be as literal as possible. So yes, I live with a pain in the rear – along with about 1.4 million other Americans who have been diagnosed with ulcerative colitis (UC) and Crohn’s disease – collectively known as inflammatory bowel disease (IBD).
The biggest judicial showdown in quite a while is finally over, and here are a couple of things to consider while we’re playing numerology games in an effort to interpret the scribblings of nine citizens in black robes we all now refer to as SCOTUS.
The highest court in the land is poised to make a ruling that will undoubtedly change the face of healthcare forever. As the Supreme Court is set to bury or uphold President Obama's presidential campaign healthcare plan, there should be one question that people should be asking no matter what the outcome is.
The story of the transcatheter aortic valve implant is well underway thanks to the fact that the Sapien valve, made by Edwards Lifesciences, is on the market, but there is more to this story. Following are three aspects of the TAVR story that bear watching.
OK, social media mavens – this one’s for you.
This coming from someone who, whenever I see or hear a reference to a Tweet, automatically rack up the chorus to Bobby Day’s golden oldie “Rockin’ Robin” (yes, and the Jackson 5, but Bobby Day’s was the original, in 1958):
With all the acrimony between Democrats and Republicans in Congress these days, it was truly edifying to see lawmakers on both sides of the aisle agreeing on a piece of legislation - and in the healthcare sector no less - the FDA user fee reauthorization act.